In 2022, the global pharmaceutical industry valued USD 1.5 trillion, if not more. But, did you know that anything between USD 90 and 150 billion worth of the drugs sold are not manufactured by the large pharmaceutical companies themselves, but by third-party companies, known as contract development and manufacturing organizations, or CDMOs?